Study identifier:NIS-ORU-IRE-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Epidemiological study to describe NSCLC clinical management patterns in Central Eastern Europe and Russia. Lung-EPICLIN
Non Small Cell Lung Cancer
-
No
-
All
840
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 May 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Non-small cell lung cancer patients | - |